Merck | MRK - Cost Of Sales



Merck reported EUR2.23B in Cost of Sales for its fiscal quarter ending in June of 2025.


Cost Of Sales Change Date
Adidas EUR 2.88B 73M Jun/2025
Adyen EUR 119.59M 54.16M Dec/2024
Akzo Nobel EUR 1.59B 23M Jun/2025
Alcon AG USD 1.21B 118M Jun/2025
Amadeus IT EUR 543.1M 131.4M Jun/2025
Amarin USD 16.89M 18.51M Mar/2025
AstraZeneca USD 2.47B 232M Jun/2025
BASF EUR 11.59B 957M Jun/2025
Bayer EUR 4.36B 1.26B Jun/2025
Beiersdorf EUR 2.11B 130M Jun/2025
Covestro EUR 2.83B 185M Jun/2025
Danone EUR 6.74B 59M Jun/2025
Fresenius EUR 4.12B 117M Jun/2025
Fresenius Medical Care EUR 3.58B 120M Jun/2025
Galapagos EUR 4.71M 9.02M Jun/2025
Genmab DKK 57M 15M Jun/2025
Givaudan CHF 1.05B 936.5M Jun/2024
GlaxoSmithKline GBP 2.16B 241M Jun/2025
GRIFOLS EUR 1.15B 56.19M Jun/2025
Henkel EUR 5.07B 260M Jun/2025
Hikma Pharmaceutical USD 895M 82M Dec/2024
Infineon EUR 2.18B 16M Jun/2025
Linde USD 4.31B 14M Jun/2025
Lonza CHF 2.47B 532M Dec/2024
Merck EUR 2.23B 93M Jun/2025
Novartis USD 3.32B 95M Jun/2025
Philips EUR 2.33B 79M Jun/2025
Roche Holding CHF 4.13B 393.5M Dec/2024
Sanofi EUR 2.99B 103M Jun/2025
UCB EUR 901M 50M Dec/2024